OLEMA PHARMACEUTICALS INC. - COMMON STOCK

Olema Oncology to Present at Cowen 42nd Annual Health Care Conference

22 Feb 2022 07:30:00 By Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03 Feb 2022 17:00:00 By Nasdaq GlobeNewswire

Olema Oncology Appoints Naseem Zojwalla, M.D., as Chief Medical Officer

31 Jan 2022 07:30:00 By Nasdaq GlobeNewswire

Olema Oncology to Present at 40th Annual J.P. Morgan Healthcare Conference

04 Jan 2022 07:30:00 By Nasdaq GlobeNewswire

Olema Oncology Announces First Clinical Data on OP-1250 in Advanced ER+ / HER2- Breast Cancer

30 Nov 2021 07:00:00 By Nasdaq GlobeNewswire

Olema Oncology Issues Statement Regarding Falsified Information Circulating on Social Media

29 Nov 2021 16:27:08 By Nasdaq GlobeNewswire

Olema Oncology to Present New Data on OP-1250 at 2021 San Antonio Breast Cancer Symposium

22 Nov 2021 07:30:00 By Nasdaq GlobeNewswire

Olema Oncology Reports Third Quarter 2021 Financial Results and Provides Corporate Update

10 Nov 2021 16:05:00 By Nasdaq GlobeNewswire

Olema Oncology to Present at Two Upcoming Investor Conferences

09 Nov 2021 07:30:00 By Nasdaq GlobeNewswire

Olema Oncology Announces Trials in Progress Poster on OP-1250 at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

30 Sep 2021 17:00:00 By Nasdaq GlobeNewswire

Olema Oncology to Present Data on OP-1250 at the 2021 JCA-AACR Precision Cancer Medicine International Conference

09 Sep 2021 07:30:00 By Nasdaq GlobeNewswire

Olema Oncology to Present at Morgan Stanley 19th Annual Global Healthcare Conference

30 Aug 2021 16:05:00 By Nasdaq GlobeNewswire

Olema Oncology Reports Second Quarter 2021 Financial Results and Provides Corporate Update

10 Aug 2021 16:05:01 By Nasdaq GlobeNewswire

Olema Oncology to Participate at the Jefferies 2021 Virtual Healthcare Conference

18 May 2021 16:05:00 By Nasdaq GlobeNewswire

Olema Oncology Reports First Quarter 2021 Financial Results and Provides Corporate Update

11 May 2021 16:05:01 By Nasdaq GlobeNewswire

Olema Oncology to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference

07 Apr 2021 07:30:00 By Nasdaq GlobeNewswire

Olema Oncology Appoints Oncology Biotech Executive Yi Larson, MBA, to Board of Directors

06 Apr 2021 07:30:00 By Nasdaq GlobeNewswire

Olema Oncology Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Updates

17 Mar 2021 16:05:00 By Nasdaq GlobeNewswire

Olema Oncology Announces Late-Breaking Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2021

10 Mar 2021 16:45:00 By Nasdaq GlobeNewswire

Olema Oncology to Participate at Upcoming Virtual Investor Conferences

23 Feb 2021 07:00:01 By Nasdaq GlobeNewswire